Integrated Use of PD-1 Inhibition and Transarterial Chemoembolization for Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Retrospective, Propensity Score-Matched Study
| dc.contributor.author | Muzaffar, Mahvish | |
| dc.contributor.author | Marinelli, Brett | |
| dc.date.accessioned | 2023-02-03T20:59:15Z | |
| dc.date.available | 2023-02-03T20:59:15Z | |
| dc.date.issued | 2022 | |
| dc.identifier.doi | 10.1136/jitc-2021-004205 | |
| dc.identifier.issn | 2051-1426 | |
| dc.identifier.uri | http://hdl.handle.net/10342/12171 | |
| dc.language.iso | en_US | en_US |
| dc.subject | Transarterial chemoembolization | en_US |
| dc.subject | Nivolumab | en_US |
| dc.subject | hepatocellular carcinoma | en_US |
| dc.title | Integrated Use of PD-1 Inhibition and Transarterial Chemoembolization for Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Retrospective, Propensity Score-Matched Study | en_US |
| dc.type | Article | en_US |
| ecu.journal.issue | 6 | en_US |
| ecu.journal.name | Journal for ImmunoTherapy of Cancer | en_US |
| ecu.journal.volume | 10 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- MuzaffarIntegratedUseofPD1InhibitionandTransarterialChemoembolizationforHepatocellularCarcinoma.pdf
- Size:
- 2.28 MB
- Format:
- Adobe Portable Document Format
- Description: